J&J Innovative Medicine

Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the first quarter of 2018 in this recap of Johnson & Johnson’s latest earnings report.

See how the company’s consumer, pharmaceutical and medical devices businesses performed in 2017 in this breakdown of its latest annual earnings report.

The company has once again been recognized for its commitment to employees, innovation and the health and well-being of people around the world.

As the International AIDS Society Conference on HIV Science kicks off, we’re spotlighting researchers who’ve dedicated their life’s work to tackling the epidemic in groundbreaking ways.

Each year, Johnson & Johnson recognizes a scientist whose work has the potential to transform human health. We caught up with this year’s winner, who has dedicated his career to studying the powers of mitochondrial DNA.

Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals, shares how the transaction will help expand the company’s portfolio of transformational therapies.

A groundbreaking partnership between countries, health organizations and companies worldwide—including Johnson & Johnson—hopes to find the most promising vaccines to help protect people from the virus.

On International Women’s Day, we’re spotlighting inspiring Johnson & Johnson employees who work year-round to improve the health, safety and trajectory of women worldwide.

When Janssen Pharmaceuticals merged with Johnson & Johnson in February 1961, a fruitful collaboration that continues to this day was born. Learn about the man who coined over 100 patents and developed more than a dozen life-changing medications.

When Rick Martinez learned he had cancer, his professional life at Johnson & Johnson turned personal: He suddenly found himself the subject of a clinical trial. For National Cancer Prevention Month, he shares his story.